uric acid has been researched along with glucagon-like peptide 1 in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 5 (62.50) | 2.80 |
| Authors | Studies |
|---|---|
| Astrup, A; Bibby, BM; Buemann, B; Holst, JJ; Rehfeld, JF; Toubro, S | 1 |
| Aoyama, N; Izumi, T; Masuda, T; Matsunaga, A; Takahira, N; Tojo, T; Yamaoka-Tojo, M | 1 |
| Cazzo, E; Chaim, E; Geloneze, B; Geloneze, SR; Hirsch, FF; Pareja, JC | 1 |
| Abdel-Aal, M; Abdel-Ghany, RH; Alsemeh, AE; Ghareib, SA; Wahba, NS | 1 |
| Beglinger, C; Dellatorre-Teixeira, L; Drewe, J; Hartmann, B; Holst, JJ; Meyer-Gerspach, AC; Peterli, R; Rehfeld, JF; Roux, CWL; Tack, J; Verbeure, W; Wölnerhanssen, BK | 1 |
| Bahrami, M; Butler, AE; Najafi, S; Sahebkar, A | 2 |
| Doumas, M; Papadopoulos, C; Patoulias, D | 1 |
1 review(s) available for uric acid and glucagon-like peptide 1
| Article | Year |
|---|---|
The effect of glucagon-like peptide-1 receptor agonists on serum uric acid concentration: A systematic review and meta-analysis.
Topics: Diabetes Mellitus, Type 2; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Glucose; Humans; Hypoglycemic Agents; Insulin; Metformin; Sodium-Glucose Transporter 2 Inhibitors; Uric Acid | 2022 |
1 trial(s) available for uric acid and glucagon-like peptide 1
| Article | Year |
|---|---|
Effect of the Natural Sweetener Xylitol on Gut Hormone Secretion and Gastric Emptying in Humans: A Pilot Dose-Ranging Study.
Topics: Adult; Blood Glucose; Cholecystokinin; Cross-Over Studies; Dipeptides; Double-Blind Method; Female; Gastric Emptying; Gastric Inhibitory Polypeptide; Gastrointestinal Hormones; Glucagon; Glucagon-Like Peptide 1; Humans; Insulin; Lipids; Male; Sweetening Agents; Uric Acid; Xylitol; Young Adult | 2021 |
6 other study(ies) available for uric acid and glucagon-like peptide 1
| Article | Year |
|---|---|
D-tagatose, a stereoisomer of D-fructose, increases blood uric acid concentration.
Topics: Administration, Oral; Adult; Appetite; Blood Glucose; Calorimetry, Indirect; Cholecystokinin; Cross-Over Studies; Double-Blind Method; Energy Metabolism; Epinephrine; Food-Drug Interactions; Fructose; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Hexoses; Humans; Male; Norepinephrine; Peptide Fragments; Protein Precursors; Stereoisomerism; Sweetening Agents; Uric Acid | 2000 |
Elevated circulating levels of an incretin hormone, glucagon-like peptide-1, are associated with metabolic components in high-risk patients with cardiovascular disease.
Topics: Adult; Aged; Biomarkers; Blood Glucose; Cardiovascular Diseases; Chi-Square Distribution; Cholesterol, HDL; Cross-Sectional Studies; Diabetes Mellitus; Enzyme-Linked Immunosorbent Assay; Fasting; Female; Gastric Inhibitory Polypeptide; Glucagon-Like Peptide 1; Glycated Hemoglobin; Humans; Insulin Resistance; Japan; Logistic Models; Male; Metabolic Syndrome; Middle Aged; Obesity, Abdominal; Odds Ratio; Risk Assessment; Risk Factors; Triglycerides; Up-Regulation; Uric Acid; Waist Circumference | 2010 |
Comparison of metabolic effects of surgical-induced massive weight loss in patients with long-term remission versus non-remission of type 2 diabetes.
Topics: Adiponectin; Adolescent; Adult; Area Under Curve; Blood Glucose; Body Mass Index; Brazil; C-Reactive Protein; Diabetes Mellitus, Type 2; Female; Gastric Bypass; Glucagon-Like Peptide 1; Humans; Incretins; Leukocytes; Male; Middle Aged; Obesity, Morbid; Remission Induction; Retrospective Studies; Uric Acid; Weight Loss; Young Adult | 2012 |
Vitamin D3 potentiates the renoprotective effects of vildagliptin in a rat model of fructose/salt-induced insulin resistance.
Topics: AMP-Activated Protein Kinases; Animals; Blood Glucose; Cholecalciferol; Creatinine; Dipeptidyl-Peptidase IV Inhibitors; Glucagon-Like Peptide 1; Hyperuricemia; Hypoglycemic Agents; Insulin Resistance; Kidney; Kidney Cortex; Male; Malondialdehyde; MAP Kinase Signaling System; NADP; Oxidative Stress; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Sirtuin 1; Sodium Chloride; Transforming Growth Factor beta1; Tumor Necrosis Factor-alpha; Urea; Uric Acid; Vildagliptin | 2020 |
Cardiovascular protection conferred by glucagon-like peptide-1 receptor agonists: A role for serum uric acid reduction?
Topics: Cardiovascular Diseases; Cardiovascular System; Diabetes Mellitus, Type 2; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Humans; Hypoglycemic Agents; Uric Acid | 2022 |
Serum uric acid lowering mediated by glucagon-like peptide-1 receptor agonists: Emerging considerations.
Topics: Diabetes Mellitus, Type 2; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Humans; Hypoglycemic Agents; Uric Acid | 2022 |